Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
Douglas D. Fraser(Western University), Gediminas Cepinskas(Western University), Michael R. Miller(Western University), David B. O’Gorman(Western University), Claudio M. Martin(Western University), Marat Slessarev(Western University), Mark Daley(Western University), Maitray A. Patel(Western University), Sean E. Gill(Western University), David S. Wishart(University of Alberta), Rupasri Mandal(University of Alberta), Eric K. Patterson(Lawson Health Research Institute)
Cited by 121
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
The Human Serum Metabolome
|PLoS ONE|2011|1.7k
1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects
|Journal of Biomolecular NMR|1995|1.6k
DrugBank 6.0: the DrugBank Knowledgebase for 2024
|Nucleic Acids Research|2023|1.4k
The Human Urine Metabolome
|PLoS ONE|2013|1.4k